|Home > Research|
People in Research
Buddy D. Ratner, Ph.D., Director
These examples illustrate some problems we have with implanted medical devices. On the positive side, medical devices are implanted into millions of people each year and largely, lives are saved or the quality of life is improved.
UWEB focuses on today's medical implants. These implants are responsible for a substantial part of a $100B+ medical device industry. UWEB endeavors to improve the performance and safety of current biomaterials used in medical devices.
UWEB is comprised of professors, students, technical staff and industry companies who are members of the UWEB consortium. UWEB researchers are divided into three thrusts: materials and surfaces, basic biology and clinical and healing sciences. The basic biology discoveries on healing and inflammation from thrust two are translated into materials concepts in thrust one and then delivered for in vivo testing in thrust three.
There are some ideas that are central to UWEB:
The central concept driving UWEB research and engineering is illustrated in this simple diagram:
Today, the body walls off implanted materials as foreign bodies. We ask if it is not possible in the future to get materials to cleanly integrate with the body using the process called normal wound healing.
Since the 1996 launch of UWEB, new developments have expanded the horizons of biomaterials. In particular, matricellular proteins have revealed clues about healing, tissue engineering has opened possibilities for combining living cells and materials, knock-out animals have provided a new way to explore biological pathways in vivo, adult stem cells have extended what we might accomplish and gene delivery, anti-sense technology and siRNA methods may allow direct control of cells involved in healing. The principles central to UWEB (inflammation, biomolecules at surfaces, advances in modern biology) are consistent with new biomaterials ideas for advancing the performance of today's biomaterials.
A large number of specific technical advances have occurred that contribute to our economically and societally important goal of "biomaterials that heal." An abbreviated listing of advances includes novel biorecognition surfaces by templating, an ultrasound drug delivery system, a new class of low cost, biocompatible hydrogels based on amino acids, rational immobilization of key biomolecules to make them more effective at delivering signals, microfiber meshes that heal with no fibrous capsule, new insights into the mechanism of wound healing, desirable properties of hyaluronic acid coatings for controlling inflammation, templated porous gels for angiogeneis and advances in the biology that may lead to a cell-produced elastin vascular graft. Each of these developments has the potential to impact the advancement of fundamental knowledge and the clinical practice of medicine. These developments are hallmarked by creative ideas and outstanding researchers who are receiving worldwide recognition for their efforts.
UWEB uses the platform of medical devices and biomaterials to accomplish two goals. One, of course, is helping people by leading to improved medical devices. The second capitalizes on the intrinsic interest that young people have in medicine, anatomy and futuristic topics like bionics. UWEB is now directly interfacing with students in middle schools, high schools and community colleges. Other programs focus on undergrads and middle school science teachers. Our development of CD-ROM based educational games may reach millions of students. To bring enhanced diversity into the UWEB student group, we are "priming the pipeline" by bringing into our classrooms groups of students from the African American Academy of Seattle (our SET-UP program), focusing special attention on making them feel good about science, building their confidence in their abilities to do science, and staying in contact with them as they work their way through high school and hopefully into undergraduate programs.
Today, UWEB is learning the secrets of the biology of inflammation and wound healing and applying these ideas to biomaterials. We are moving rapidly to bring these ideas to medical devices and to commercial application. This is our last year as a National Science Foundation Engineering Research Center, but as we move into the 21st Century, we will continue and grow the UWEB concept via funding from the State, the Federal Government and Industry and expand UWEB to the next level. UWEB-21 will address needs for biomaterials in the 21st Century.
News article in the Xconomy: University of Washington Engineered Biomaterials (UWEB) Transitions into the 21st Century.
Areas of exploration that UWEB-21 will focus on include:
Device centered infection
Glucose sensor performance
Healing in soft tissues
Long-term (in vivo) non-fouling
Tissue engineering and tissue regeneration scaffolds
Neural and stimulatory electrodes
Gene, protein and cell chips
Shoulder and orthopedic joint reconstructions
Biosensors for pathogens